Surrozen, Inc./DE - 8-K Filing

Surrozen received FDA clearance for IND application of SZN-8141 and expects $95.1M in proceeds from a second closing on October 20, 2026. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $SRZN

Read the full article at SEC EDGAR

More Regulatory news